Jason Duncan

General Counsel

Mr. Duncan joins Albireo with more than 15 years of legal and compliance experience in the pharmaceutical industry. He most recently served as General Counsel at Stallergenes Greer, where he oversaw all legal activities for the allergy immunotherapy company’s Americas business. Previously, Mr. Duncan was Vice President, Head of Compliance and Legal for Sobi, a global biopharmaceutical company focused on rare inflammatory and genetic diseases. At Sobi, Mr. Duncan was responsible for all legal and compliance matters for the company’s North American affiliates, and served on the leadership team. Prior to Sobi, Mr. Duncan held roles of increasing responsibility at EMD Serono, culminating in his position as Associate General Counsel for Neurology and Discovery.

Team members

Ron Cooper

President and Chief Executive Officer

Martha (Muffy) Carter

Chief Regulatory Officer

Jason Duncan

General Counsel

Per-Göran Gillberg, Ph.D., Prof.

Vice President, Development and Co-Founder

Jan Mattsson, Ph.D.

Chief Operating Officer and Co-Founder

Simon Harford

Chief Financial Officer

Patrick Horn, M.D., Ph.D.

Chief Medical Officer

Kristina Torfgård, Ph.D.

Vice President, Global Project Head